Drug · DIN 02192632 · Veterinary
PROGRAM SUSPENSION
7%. 266MG PER DOSE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 30, 2026; first marketed February 17, 1998.
- Drug Identification Number (DIN)
- 02192632
- Company (DIN owner)
- Elanco Canada LimitedGuelph, Ontario, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Suspension
- Route
- Oral
- Class
- Veterinary
- Record last updated
- October 8, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LUFENURON | 266 MG | AMP |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 20, 2015: NOC 17497New Drug Submission (NDS) · Merger - buyout
- February 14, 2007: NOC 8586Supplement to a New Drug Submission (SNDS) · Change in manufacturing site
- September 5, 1997: NOC 6799New Drug Submission (NDS)
- November 14, 1995: NOC 7157New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “program”. A notice may cover another product or only some lots: read it to see what it covers.
- ISTODAX (romidepsin) – Restricted Access ProgramMarch 20, 2023 · Drugs · New safety information - Product withdrawal
Other DINs named PROGRAM SUSPENSION
- DIN 02057832 · Cancelled Post Market